IntelGenx Corp. Closes $3.5 Million Public Offering

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAINT LAURENT, Quebec, Dec. 16, 2013 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (OTCQX:IGXT) (TSX-V:IGX) ("IntelGenx"), a drug delivery company focused on the development of novel oral rapidly disintegrating delivery systems including its proprietary VersaFilmâ„¢ technology, as well as oral controlled-release products, announced today that it has closed a registered public offering to raise gross proceeds of approximately $3.5 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news